Compare RGEN & ZWS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RGEN | ZWS |
|---|---|---|
| Founded | 1981 | 1892 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.1B | 7.9B |
| IPO Year | 1995 | 2008 |
| Metric | RGEN | ZWS |
|---|---|---|
| Price | $123.29 | $47.26 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 6 |
| Target Price | ★ $173.09 | $49.33 |
| AVG Volume (30 Days) | 767.3K | ★ 774.6K |
| Earning Date | 05-27-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 0.93% |
| EPS Growth | ★ 286.96 | 25.00 |
| EPS | 0.86 | ★ 1.15 |
| Revenue | $141,236,000.00 | ★ $1,530,500,000.00 |
| Revenue This Year | $14.11 | $6.90 |
| Revenue Next Year | $14.71 | $5.13 |
| P/E Ratio | $139.37 | ★ $41.12 |
| Revenue Growth | ★ 35.10 | 19.40 |
| 52 Week Low | $102.97 | $27.74 |
| 52 Week High | $175.77 | $53.17 |
| Indicator | RGEN | ZWS |
|---|---|---|
| Relative Strength Index (RSI) | 33.82 | 34.23 |
| Support Level | $121.25 | $45.14 |
| Resistance Level | $132.51 | $48.40 |
| Average True Range (ATR) | 6.58 | 1.25 |
| MACD | -0.05 | -0.57 |
| Stochastic Oscillator | 15.23 | 27.37 |
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.
Zurn Elkay Water Solutions Corp is a growth-oriented, pure-play water management business that designs, procures, manufactures, and markets the broadest sustainable product portfolio of specification-driven water management solutions to improve health, hydration, human safety and the environment. Its product portfolio includes professional grade water safety and control products, flow systems products, hygienic and environmental products, and filtered drinking water products for public and private spaces that deliver superior value to building owners, positively impact the environment and human hygiene and reduce product installation time.